Novo Nordisk A/S (NOVO)
Market Closed
12 Jun, 20:00
TSX TSX Primary CA$
18. 55
-0.12
-0.6427%
CA$
807.7B Market Cap
48.26 P/E Ratio
0.32% Div Yield
2,781 Volume
0 Eps
CA$ 18.67
Previous Close Want to track NOVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S (NOVO) Statistics
Valuation metrics
Market Cap 807.7B
Enterprise value 188.08B
Trailing P/E (ttm) 3.18
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 0.27
Price/Book (mrq) 0.41
Enterprise Value/Revenue 0.61
Enterprise Value/EBITDA 1.25
Overview
Shares outstanding 4.44B
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8.6K
Average volume (90 days) 11.39K
Price summary
52-Week low 14.88
52-Week high 27.58
Beta -
50-Day moving average 17.02
200-Day moving average 19.31
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.81%
Operating margin 0.44%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.53%
Income Statement
Revenue (ttm) 309.06B
Revenue per share (ttm) 69.56
Quarterly revenue growth (yoy) 0.22%
Gross profit (ttm) 250.28B
EBITDA 181.54B
Net income to common (ttm) 102.43B
Diluted EPS (ttm) 23.03
Quarterly earnings growth (yoy) 0.24%
Balance Sheet
Total cash (mrq) 21.13B
Total cash per share (mrq) 4.76
Total debt (mrq) 146.38B
Total Debt/Equity (mrq) 0.72
Current ratio (mrq) 0.79%
Book value per share (mrq) 45.71
Cash Flow
Cash flow statement 149.4B
Levered free cash flow (LFCF) 102.43B
